4-Octyl itaconate通过调节HMOX-1信号传递,部分抑制了血管化
Qianqian Dong1, Fang Liu1, Jiahui Zhu1
1Department of Cardiology, Laboratory of Heart Center, Heart Center, Zhujiang Hospital, Southern Medical University, China; Guangdong Provincial Key Laboratory of Cardiac Function and Microcirculation, Guangdong Provincial Biomedical Engineering Technology Research Center for Cardiovascular Disease, China.
European journal of pharmacology
|November 12, 2024
概括
4-Octyl itaconate (4-OI) 通过抑制炎症和氧化应激,可以减少血管化. 这种效应通过血红素酶1 (HMOX-1) 途径进行介导,这表明4-OI是潜在的治疗标.
科学领域:
- 生物化学 生物化学
- 心血管生物学 心血管生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 血管化是慢性病,糖尿病和高血压等慢性疾病中心血管事件的重要贡献者.
- 确定抑制血管化的治疗点对于患者的治疗结果至关重要.
- 4-Octyl itaconate (4-OI) 是一种新的 itaconate衍生物,具有抗炎和抗氧化特性,但其在血管化中的作用尚不清楚.
研究的目的:
- 研究4-Octyl itaconate (4-OI) 在缓解血管化的治疗潜力.
- 阐明4-OI影响血管化,炎症和氧化应激的潜在分子机制.
主要方法:
- 利用人类血管光滑肌细胞 (VSMCs),动脉环,以及血管化的小鼠模型.
- 评估化和骨质分化,使用阿利扎林红色染色和西方涂抹.
- 采用RNA测序来识别4-OI的分子标.
- 使用siRNA倒置和特定抑制剂研究了血红素氧酶1 (HMOX-1) 的作用.
主要成果:
- 4-Octyl itaconate (4-OI) 显著抑制了VSMC化和骨质分化的发生.
- 4-OI在动脉环和小鼠大动脉中显示出对化的保护作用.
- RNA测序确定了血红氧酶1 (HMOX-1) 作为一个关键的媒介,4-OI上调HMOX-1表达.
- 在VSMC中,4-OI抑制了炎症和氧化应激,其作用取决于HMOX-1活性.
- 抑制HMOX-1逆转了4-OI的抗化和抗炎作用.
结论:
- 4-奥克伊塔科纳酸 (4-OI) 有效地缓解了血管化.
- 4-OI的治疗益处归因于它通过HMOX-1通路抑制氧化应激和炎症的能力.
- 4-OI是治疗血管化的有希望的候选药物.
相关概念视频
Antihypertensive Drugs: Action of Calcium Channel Blockers
459
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
459
Calmodulin-dependent Signaling
5.1K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.1K


